CSNpharm
Sulfamerazine is a sulfanilamide antibacterial agent working by inhibiting bacterial synthesis of dihydrofolic acid through competing with PABA (para-aminobenzoic acid) for binding to dihydropteroate synthetase (dihydrofolate synthetase).
More Information
Supplier Page
CSNpharm
Sulfamerazine is a sulfanilamide antibacterial agent working by inhibiting bacterial synthesis of dihydrofolic acid through competing with PABA (para-aminobenzoic acid) for binding to dihydropteroate synthetase (dihydrofolate synthetase).
More Information
Supplier Page
CSNpharm
Sulfamerazine is a sulfanilamide antibacterial agent working by inhibiting bacterial synthesis of dihydrofolic acid through competing with PABA (para-aminobenzoic acid) for binding to dihydropteroate synthetase (dihydrofolate synthetase).
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Pyridostatin Trifluoroacetate stabilizes and binds G-quadruplexe with Kd of 490 nM (cell-free assay), which targets the proto-oncogene c-kit, K-ras and Bcl-2.
More Information
Supplier Page
CSNpharm
Pyridostatin Trifluoroacetate stabilizes and binds G-quadruplexe with Kd of 490 nM (cell-free assay), which targets the proto-oncogene c-kit, K-ras and Bcl-2.
More Information
Supplier Page
CSNpharm
Pyridostatin Trifluoroacetate stabilizes and binds G-quadruplexe with Kd of 490 nM (cell-free assay), which targets the proto-oncogene c-kit, K-ras and Bcl-2.
More Information
Supplier Page
AS101
1mg
| ≥98%
CSNpharm
AS101 is a potent Caspase-1 inhibitor which can inhibit IL-10 synthesis and potentiates IL-1α, IL-2 and TNF-α release through Caspase, performing as an immunomodulator.
More Information
Supplier Page
AS101
25mg
| ≥98%
CSNpharm
AS101 is a potent Caspase-1 inhibitor which can inhibit IL-10 synthesis and potentiates IL-1α, IL-2 and TNF-α release through Caspase, performing as an immunomodulator.
More Information
Supplier Page